GABA A receptor: Positive and negative allosteric modulators.
Level 5 - mechanism / opinion, no new human data
Narrative review of receptor pharmacology mechanisms without systematic review or new empirical data.
PubMed 29407219 · doi:10.1016/j.neuropharm.2018.01.036
What was done
Narrative review synthesizing the structural, regional, and functional pharmacology of GABA_A receptor subtypes. The author outlines the receptor family's subunit diversity and describes the mechanisms and binding sites through which positive and negative allosteric modulators—including benzodiazepines, general anesthetics, neurosteroids, and ethanol—regulate inhibitory neurotransmission.
What was found
The abstract reports qualitative pharmacological relationships without numerical data or effect estimates. GABA_A receptors are heteropentameric chloride channels formed from combinations of 19 possible subunits with distinct brain localization, developmental expression, and plastic regulation. Benzodiazepine anxiolytics and sedatives bind to subtype-dependent extracellular domain sites. General anesthetics and neurosteroids modulate transmembrane subunit interfaces. Ethanol exhibits dose-dependent site specificity, targeting extracellular sites at low intoxicating concentrations and transmembrane domain sites at high anesthetic doses.
Why it matters
It maps how structurally diverse clinical drugs (sedatives, anesthetics, anxiolytics) achieve distinct pharmacological profiles by targeting discrete allosteric binding sites across GABA_A receptor subtypes.
Limits
The abstract reports no primary experimental or clinical data, statistical comparisons, or quantitative metrics. As a narrative review, it lacks systematic search criteria, quality appraisal of cited literature, and pre-specified inclusion criteria.
Cited by
- supports Alcohol acts as an anxiolytic.